1. New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials
   Peng He et al, 2023, Environmental Research CrossRef
2. Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration
   Zhongbao Zhou et al, 2022, Journal of Oncology CrossRef
3. Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma
   Heng Zhang et al, 2017, Oncotarget CrossRef
4. Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
   Swathi Ramakrishnan et al, 2017, Cell Death & Disease CrossRef
5. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
   Nasim Ebrahimi et al, 2024, Cancer and Metastasis Reviews CrossRef
6. Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer
   Gerald B. Schulz et al, 2021, Cancer Science CrossRef